Toxoplasmosis in Transplant Recipients, Europe, 2010–2014
Supporting Files
Public Domain
-
August 2018
-
File Language:
English
Details
-
Alternative Title:Emerg Infect Dis
-
Personal Author:Robert-Gangneux, Florence ; Meroni, Valeria ; Dupont, Damien ; Botterel, Françoise ; Garcia, José M. Aguado ; Brenier-Pinchart, Marie-Pierre ; Accoceberry, Isabelle ; Akan, Hamdi ; Abbate, Isabella ; Boggian, Katia ; Bruschi, Fabrizio ; Carratalà, Jordi ; David, Miruna ; Drgona, Lubos ; Djurković-Djaković, Olgica ; Farinas, Maria Carmen ; Genco, Francesca ; Gkrania-Klotsas, Effrossyni ; Groll, Andreas H. ; Guy, Edward ; Hirzel, Cédric ; Khanna, Nina ; Kurt, Özgür ; Junie, Lia Monica ; Lazzarotto, Tiziana ; Len, Oscar ; Mueller, Nicolas J. ; Munoz, Patricia ; Pana, Zoi Dorothea ; Roilides, Emmanuel ; Stajner, Tijana ; van Delden, Christian ; Villena, Isabelle ; Pelloux, Hervé ; Manuel, Oriol
-
Description:Transplantation activity is increasing, leading to a growing number of patients at risk for toxoplasmosis. We reviewed toxoplasmosis prevention practices, prevalence, and outcomes for hematopoietic stem cell transplant (HSCT) and solid organ transplant (SOT; heart, kidney, or liver) patients in Europe. We collected electronic data on the transplant population and prevention guidelines/regulations and clinical data on toxoplasmosis cases diagnosed during 2010-2014. Serologic pretransplant screening of allo-hematopoietic stem cell donors was performed in 80% of countries, screening of organ donors in 100%. SOT recipients were systematically screened in 6 countries. Targeted anti-Toxoplasma chemoprophylaxis was heterogeneous. A total of 87 toxoplasmosis cases were recorded (58 allo-HSCTs, 29 SOTs). The 6-month survival rate was lower among Toxoplasma-seropositive recipients and among allo-hematopoietic stem cell and liver recipients. Chemoprophylaxis improved outcomes for SOT recipients. Toxoplasmosis remains associated with high mortality rates among transplant recipients. Guidelines are urgently needed to standardize prophylactic regimens and optimize patient management.
-
Subjects:
-
Source:Emerg Infect Dis. 24(8):1497-1504
-
Pubmed ID:30014843
-
Pubmed Central ID:PMC6056100
-
Document Type:
-
Place as Subject:
-
Location:
-
Volume:24
-
Issue:8
-
Collection(s):
-
Main Document Checksum:urn:sha256:a335c4cb0de510aba0e211c560e937a1b570b7bbf04f760dc852ea5accaa0444
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
Emerging Infectious Diseases